Appetite and Satiety Control-Gut Mechanisms
The prevalence of obesity and its comorbidities, particularly type 2 diabetes, cardiovascular and hepatic disease and certain cancers, continues to rise worldwide. Paradoxically, despite an increasingly obesogenic environment, particularly in Western societies, undernutrition is also extremely commo...
Uloženo v:
| Další autoři: | , |
|---|---|
| Médium: | Kapitola |
| Vydáno: |
Basel, Switzerland
MDPI - Multidisciplinary Digital Publishing Institute
2021
|
| Témata: | |
| On-line přístup: | Get Fullteks DOAB: description of the publication |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|
| LEADER | 06349naaaa2201741uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_77009 | ||
| 005 | 20220111 | ||
| 020 | |a books978-3-0365-2347-7 | ||
| 020 | |a 9783036523484 | ||
| 020 | |a 9783036523477 | ||
| 024 | 7 | |a 10.3390/books978-3-0365-2347-7 |c doi | |
| 041 | 0 | |a English | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 100 | 1 | |a Feinle-Bisset, Christine |4 edt | |
| 700 | 1 | |a Horowitz, Michael |4 edt | |
| 700 | 1 | |a Feinle-Bisset, Christine |4 oth | |
| 700 | 1 | |a Horowitz, Michael |4 oth | |
| 245 | 1 | 0 | |a Appetite and Satiety Control-Gut Mechanisms |
| 260 | |a Basel, Switzerland |b MDPI - Multidisciplinary Digital Publishing Institute |c 2021 | ||
| 300 | |a 1 electronic resource (454 p.) | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a The prevalence of obesity and its comorbidities, particularly type 2 diabetes, cardiovascular and hepatic disease and certain cancers, continues to rise worldwide. Paradoxically, despite an increasingly obesogenic environment, particularly in Western societies, undernutrition is also extremely common. The application of novel, sophisticated techniques, particularly related to imaging and molecular biology, has substantially advanced our understanding of the mechanisms controlling appetite and energy intake. This has led to a redefinition of many concepts, including the relative importance of central versus peripheral mechanisms, recognising that the gastrointestinal (GI) tract, particularly gut hormones, plays a critical role. Given the major advance in knowledge in the field, this Special Issue provides a comprehensive overview of the GI mechanisms underlying the regulation of appetite and energy intake, as a series of definitive reviews by international authorities. The reviews address gut-related mechanisms, including nutrient sensing, gut hormones and GI motility, gut-brain communication, including the roles of the vagus and the modulation of reward perception, the roles of diet and the microbiota, as well as the abnormalities associated with eating disorders, specifically obesity and anorexia of ageing, and the beneficial effects of bariatric surgery. The reviews cover both preclinical research and studies in humans, and are complemented by a number of important original papers. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 653 | |a lixisenatide | ||
| 653 | |a intragastric meal retention | ||
| 653 | |a energy intake | ||
| 653 | |a type 2 diabetes | ||
| 653 | |a obesity | ||
| 653 | |a amino acid | ||
| 653 | |a isoleucine | ||
| 653 | |a chronic supplementation | ||
| 653 | |a energy expenditure | ||
| 653 | |a oral glucose tolerance test | ||
| 653 | |a glycaemic control | ||
| 653 | |a gastric emptying breath test | ||
| 653 | |a endocannabinoid | ||
| 653 | |a cannabinoid CB1 receptor | ||
| 653 | |a gut-brain | ||
| 653 | |a intestine | ||
| 653 | |a western diet | ||
| 653 | |a preference | ||
| 653 | |a whey protein | ||
| 653 | |a gastric emptying | ||
| 653 | |a appetite | ||
| 653 | |a lifecourse | ||
| 653 | |a gut hormones | ||
| 653 | |a hunger | ||
| 653 | |a protein | ||
| 653 | |a TAS2R5 | ||
| 653 | |a TAS2R39 | ||
| 653 | |a TAS2R14 | ||
| 653 | |a agonist | ||
| 653 | |a food intake | ||
| 653 | |a GLP1 | ||
| 653 | |a CCK | ||
| 653 | |a PYY | ||
| 653 | |a miniature pig | ||
| 653 | |a pig model | ||
| 653 | |a functional brain imaging | ||
| 653 | |a molecular imaging | ||
| 653 | |a vagal afferents | ||
| 653 | |a single fiber recording | ||
| 653 | |a insulin resistance | ||
| 653 | |a GLP-1r | ||
| 653 | |a gastric barostat | ||
| 653 | |a scintigraphy | ||
| 653 | |a meal ingestion | ||
| 653 | |a postprandial responses | ||
| 653 | |a hedonic sensations | ||
| 653 | |a homeostatic sensations | ||
| 653 | |a abdominal wall activity | ||
| 653 | |a abdominal distension | ||
| 653 | |a taste | ||
| 653 | |a fat | ||
| 653 | |a carbohydrate | ||
| 653 | |a bariatric surgery | ||
| 653 | |a GLP-1 | ||
| 653 | |a ghrelin | ||
| 653 | |a Roux-en-Y gastric bypass | ||
| 653 | |a gastric band | ||
| 653 | |a sleeve gastrectomy | ||
| 653 | |a circadian | ||
| 653 | |a gastrointestinal tract | ||
| 653 | |a enteroendocrine cells | ||
| 653 | |a chemosensory | ||
| 653 | |a GIP | ||
| 653 | |a nutrients | ||
| 653 | |a hormones | ||
| 653 | |a food ingestion | ||
| 653 | |a digestion | ||
| 653 | |a satiety | ||
| 653 | |a digestive well-being | ||
| 653 | |a functional gastrointestinal disorders | ||
| 653 | |a postprandial symptoms | ||
| 653 | |a brainstem | ||
| 653 | |a vagus | ||
| 653 | |a feeding | ||
| 653 | |a gastrointestinal | ||
| 653 | |a cue reactivity | ||
| 653 | |a meal anticipation | ||
| 653 | |a motivation | ||
| 653 | |a nutrient preference | ||
| 653 | |a flavor | ||
| 653 | |a aversion | ||
| 653 | |a bile acids | ||
| 653 | |a TGR-5 | ||
| 653 | |a FXR | ||
| 653 | |a gastrointestinal hormones | ||
| 653 | |a body weight | ||
| 653 | |a gastric accommodation | ||
| 653 | |a satiation | ||
| 653 | |a CB1 receptor | ||
| 653 | |a gut-brain | ||
| 653 | |a reward | ||
| 653 | |a aging | ||
| 653 | |a whey | ||
| 653 | |a anorexia | ||
| 653 | |a supplements | ||
| 653 | |a sarcopenia | ||
| 653 | |a nutrient sensing | ||
| 653 | |a enteroendocrine cells (EECs) | ||
| 653 | |a appetite regulation | ||
| 653 | |a G-protein coupled receptors (GPCRs) | ||
| 653 | |a bitter substances | ||
| 653 | |a gastric motor function | ||
| 653 | |a postprandial blood glucose | ||
| 653 | |a preclinical studies | ||
| 653 | |a human studies | ||
| 653 | |a texture | ||
| 653 | |a oro-sensory exposure | ||
| 653 | |a sensory science | ||
| 653 | |a cephalic responses | ||
| 653 | |a brain areas | ||
| 653 | |a brain stem | ||
| 653 | |a weight management | ||
| 653 | |a intestinal brake | ||
| 653 | |a duodenal jejunal and ileal brake | ||
| 653 | |a tastants | ||
| 653 | |a circadian clock | ||
| 653 | |a gastric bypass surgery | ||
| 653 | |a microbiome | ||
| 653 | |a hypothalamus | ||
| 653 | |a n/a | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/4619 |7 0 |z Get Fullteks |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/77009 |7 0 |z DOAB: description of the publication |